AGF Investments LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 257 filers reported holding HAEMONETICS CORP in Q2 2019. The put-call ratio across all filers is 2.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
AGF Investments LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2019$10,000
+11.1%
82
-16.3%
0.00%0.0%
Q1 2019$9,000
-94.8%
98
-94.4%
0.00%
-91.7%
Q4 2018$174,000
+100.0%
1,744
+134.4%
0.02%
+118.2%
Q3 2018$87,000
-7.4%
744
-28.2%
0.01%0.0%
Q2 2018$94,000
+91.8%
1,036
+64.2%
0.01%
+37.5%
Q1 2018$49,000
+22.5%
631
-2.6%
0.01%
+14.3%
Q4 2017$40,0006480.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2019
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders